- Home
- PYPD vs JZXN Comparison
PYPD vs JZXN Comparison
Compare PYPD & JZXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- JZXN
- Stock Information
- Founded
- PYPD 2008
- JZXN 2019
- Country
- PYPD Israel
- JZXN China
- Employees
- PYPD N/A
- JZXN N/A
- Industry
- PYPD Medical/Dental Instruments
- JZXN Retail-Auto Dealers and Gas Stations
- Sector
- PYPD Health Care
- JZXN Consumer Discretionary
- Exchange
- PYPD Nasdaq
- JZXN Nasdaq
- Market Cap
- PYPD 35.3M
- JZXN N/A
- IPO Year
- PYPD 2020
- JZXN 2021
- Fundamental
- Price
- PYPD $3.50
- JZXN $1.03
- Analyst Decision
- PYPD Strong Buy
- JZXN
- Analyst Count
- PYPD 5
- JZXN 0
- Target Price
- PYPD $11.40
- JZXN N/A
- AVG Volume (30 Days)
- PYPD 1.4M
- JZXN 488.4K
- Earning Date
- PYPD 08-13-2025
- JZXN 03-03-2025
- Dividend Yield
- PYPD N/A
- JZXN N/A
- EPS Growth
- PYPD N/A
- JZXN N/A
- EPS
- PYPD N/A
- JZXN N/A
- Revenue
- PYPD N/A
- JZXN $1,400,139.00
- Revenue This Year
- PYPD N/A
- JZXN N/A
- Revenue Next Year
- PYPD N/A
- JZXN N/A
- P/E Ratio
- PYPD N/A
- JZXN N/A
- Revenue Growth
- PYPD N/A
- JZXN N/A
- 52 Week Low
- PYPD $2.30
- JZXN $0.84
- 52 Week High
- PYPD $4.42
- JZXN $7.82
- Technical
- Relative Strength Index (RSI)
- PYPD 56.01
- JZXN 30.41
- Support Level
- PYPD $3.42
- JZXN $0.85
- Resistance Level
- PYPD $3.62
- JZXN $1.70
- Average True Range (ATR)
- PYPD 0.18
- JZXN 0.30
- MACD
- PYPD -0.03
- JZXN -0.00
- Stochastic Oscillator
- PYPD 60.51
- JZXN 9.31
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.